Sandia Investment Management LP bought a new position in PACS Group, Inc. (NYSE:PACS – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 10,000 shares of the company’s stock, valued at approximately $295,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PACS. Point72 DIFC Ltd bought a new stake in PACS Group during the second quarter worth about $831,000. Marshall Wace LLP bought a new stake in PACS Group in the 2nd quarter worth approximately $733,000. Davidson Kempner Capital Management LP purchased a new stake in PACS Group in the second quarter worth approximately $4,425,000. Hood River Capital Management LLC bought a new position in PACS Group during the second quarter valued at approximately $4,862,000. Finally, Sei Investments Co. purchased a new position in shares of PACS Group during the second quarter worth approximately $4,662,000.
PACS Group Stock Performance
Shares of NYSE:PACS opened at $40.45 on Wednesday. PACS Group, Inc. has a 1 year low of $22.61 and a 1 year high of $42.25. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.82. The firm’s 50-day simple moving average is $37.43.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on PACS. Stephens upped their price objective on shares of PACS Group from $37.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, August 13th. Macquarie assumed coverage on shares of PACS Group in a research report on Friday, June 28th. They set an “outperform” rating and a $35.00 price target for the company. Truist Financial lifted their price objective on PACS Group from $36.00 to $44.00 and gave the stock a “buy” rating in a report on Thursday, August 15th. Citigroup started coverage on PACS Group in a research note on Wednesday, September 11th. They issued a “buy” rating and a $45.00 target price for the company. Finally, Oppenheimer raised their price target on PACS Group from $32.00 to $40.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 13th. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $37.57.
Get Our Latest Stock Analysis on PACS Group
PACS Group Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
See Also
- Five stocks we like better than PACS Group
- What is Put Option Volume?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is Insider Trading? What You Can Learn from Insider Trading
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Roth IRA Calculator: Calculate Your Potential Returns
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding PACS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PACS Group, Inc. (NYSE:PACS – Free Report).
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.